Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect

Masashi Ikeda, Atsushi Takahashi, Yoichiro Kamatani, Yukihide Momozawa, Takeo Saito, Kenji Kondo, Ayu Shimasaki, Kohei Kawase, Takaya Sakusabe, Yoshimi Iwayama, Tomoko Toyota, Tomoyasu Wakuda, Mitsuru Kikuchi, Nobuhisa Kanahara, Hidenaga Yamamori, Yuka Yasuda, Yuichiro Watanabe, Satoshi Hoya, Branko Aleksic, Itaru KushimaHeii Arai, Manabu Takaki, Kotaro Hattori, Hiroshi Kunugi, Yuko Okahisa, Tohru Ohnuma, Norio Ozaki, Toshiyuki Someya, Ryota Hashimoto, Takeo Yoshikawa, Michiaki Kubo, Nakao Iwata

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54 479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10−10), SLC38A3 (Pbest = 5.7 × 10−10), and CABP1-ACADS (Pbest = 9.8 × 10−9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10−11) and between SCZ and BD in the JPN population (P ~ 10−40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/ lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ “risk” effect is shared with other psychiatric disorders even across populations.

Original languageEnglish
Pages (from-to)824-834
Number of pages11
JournalSchizophrenia Bulletin
Volume45
Issue number4
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Genome-Wide Association Study
Population Genetics
Schizophrenia
Genes
Bipolar Disorder
Major Depressive Disorder
Population
Psychiatry

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

Ikeda, Masashi ; Takahashi, Atsushi ; Kamatani, Yoichiro ; Momozawa, Yukihide ; Saito, Takeo ; Kondo, Kenji ; Shimasaki, Ayu ; Kawase, Kohei ; Sakusabe, Takaya ; Iwayama, Yoshimi ; Toyota, Tomoko ; Wakuda, Tomoyasu ; Kikuchi, Mitsuru ; Kanahara, Nobuhisa ; Yamamori, Hidenaga ; Yasuda, Yuka ; Watanabe, Yuichiro ; Hoya, Satoshi ; Aleksic, Branko ; Kushima, Itaru ; Arai, Heii ; Takaki, Manabu ; Hattori, Kotaro ; Kunugi, Hiroshi ; Okahisa, Yuko ; Ohnuma, Tohru ; Ozaki, Norio ; Someya, Toshiyuki ; Hashimoto, Ryota ; Yoshikawa, Takeo ; Kubo, Michiaki ; Iwata, Nakao. / Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect. In: Schizophrenia Bulletin. 2019 ; Vol. 45, No. 4. pp. 824-834.
@article{5b33b55a1de947e9b81ea4cba6c36d40,
title = "Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect",
abstract = "Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54 479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10−10), SLC38A3 (Pbest = 5.7 × 10−10), and CABP1-ACADS (Pbest = 9.8 × 10−9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10−11) and between SCZ and BD in the JPN population (P ~ 10−40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/ lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ “risk” effect is shared with other psychiatric disorders even across populations.",
author = "Masashi Ikeda and Atsushi Takahashi and Yoichiro Kamatani and Yukihide Momozawa and Takeo Saito and Kenji Kondo and Ayu Shimasaki and Kohei Kawase and Takaya Sakusabe and Yoshimi Iwayama and Tomoko Toyota and Tomoyasu Wakuda and Mitsuru Kikuchi and Nobuhisa Kanahara and Hidenaga Yamamori and Yuka Yasuda and Yuichiro Watanabe and Satoshi Hoya and Branko Aleksic and Itaru Kushima and Heii Arai and Manabu Takaki and Kotaro Hattori and Hiroshi Kunugi and Yuko Okahisa and Tohru Ohnuma and Norio Ozaki and Toshiyuki Someya and Ryota Hashimoto and Takeo Yoshikawa and Michiaki Kubo and Nakao Iwata",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/schbul/sby140",
language = "English",
volume = "45",
pages = "824--834",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "4",

}

Ikeda, M, Takahashi, A, Kamatani, Y, Momozawa, Y, Saito, T, Kondo, K, Shimasaki, A, Kawase, K, Sakusabe, T, Iwayama, Y, Toyota, T, Wakuda, T, Kikuchi, M, Kanahara, N, Yamamori, H, Yasuda, Y, Watanabe, Y, Hoya, S, Aleksic, B, Kushima, I, Arai, H, Takaki, M, Hattori, K, Kunugi, H, Okahisa, Y, Ohnuma, T, Ozaki, N, Someya, T, Hashimoto, R, Yoshikawa, T, Kubo, M & Iwata, N 2019, 'Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect', Schizophrenia Bulletin, vol. 45, no. 4, pp. 824-834. https://doi.org/10.1093/schbul/sby140

Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect. / Ikeda, Masashi; Takahashi, Atsushi; Kamatani, Yoichiro; Momozawa, Yukihide; Saito, Takeo; Kondo, Kenji; Shimasaki, Ayu; Kawase, Kohei; Sakusabe, Takaya; Iwayama, Yoshimi; Toyota, Tomoko; Wakuda, Tomoyasu; Kikuchi, Mitsuru; Kanahara, Nobuhisa; Yamamori, Hidenaga; Yasuda, Yuka; Watanabe, Yuichiro; Hoya, Satoshi; Aleksic, Branko; Kushima, Itaru; Arai, Heii; Takaki, Manabu; Hattori, Kotaro; Kunugi, Hiroshi; Okahisa, Yuko; Ohnuma, Tohru; Ozaki, Norio; Someya, Toshiyuki; Hashimoto, Ryota; Yoshikawa, Takeo; Kubo, Michiaki; Iwata, Nakao.

In: Schizophrenia Bulletin, Vol. 45, No. 4, 01.01.2019, p. 824-834.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect

AU - Ikeda, Masashi

AU - Takahashi, Atsushi

AU - Kamatani, Yoichiro

AU - Momozawa, Yukihide

AU - Saito, Takeo

AU - Kondo, Kenji

AU - Shimasaki, Ayu

AU - Kawase, Kohei

AU - Sakusabe, Takaya

AU - Iwayama, Yoshimi

AU - Toyota, Tomoko

AU - Wakuda, Tomoyasu

AU - Kikuchi, Mitsuru

AU - Kanahara, Nobuhisa

AU - Yamamori, Hidenaga

AU - Yasuda, Yuka

AU - Watanabe, Yuichiro

AU - Hoya, Satoshi

AU - Aleksic, Branko

AU - Kushima, Itaru

AU - Arai, Heii

AU - Takaki, Manabu

AU - Hattori, Kotaro

AU - Kunugi, Hiroshi

AU - Okahisa, Yuko

AU - Ohnuma, Tohru

AU - Ozaki, Norio

AU - Someya, Toshiyuki

AU - Hashimoto, Ryota

AU - Yoshikawa, Takeo

AU - Kubo, Michiaki

AU - Iwata, Nakao

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54 479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10−10), SLC38A3 (Pbest = 5.7 × 10−10), and CABP1-ACADS (Pbest = 9.8 × 10−9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10−11) and between SCZ and BD in the JPN population (P ~ 10−40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/ lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ “risk” effect is shared with other psychiatric disorders even across populations.

AB - Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54 479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10−10), SLC38A3 (Pbest = 5.7 × 10−10), and CABP1-ACADS (Pbest = 9.8 × 10−9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10−11) and between SCZ and BD in the JPN population (P ~ 10−40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/ lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ “risk” effect is shared with other psychiatric disorders even across populations.

UR - http://www.scopus.com/inward/record.url?scp=85068479502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068479502&partnerID=8YFLogxK

U2 - 10.1093/schbul/sby140

DO - 10.1093/schbul/sby140

M3 - Article

C2 - 30285260

AN - SCOPUS:85068479502

VL - 45

SP - 824

EP - 834

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 4

ER -